Symbol
AEON on NYSE
Investment type
Equity - Shares of Stock
Class
Common Stock
Latest Disclosed Ownership
108K shares
Security Ownership
9.7%

Dauntless Investment Group, LLC ownership in AEON Biopharma, Inc. Common Stock (AEON)

2025-03-03 - Dauntless Investment Group, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 108K shares of AEON Biopharma, Inc. Common Stock (AEON). This represents 9.7% percent ownership of the company.